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INTRODUCTION
Carbon monoxide (CO) poisoning is one of the leading causes of
poison-associated death (1). Although the treatment for CO poi-
soning is still not well -established and controversial, hyperbaric
oxygen therapy (HBOT) appears to prevent delayed neuropsy-
chiatric syndrome (2).
HBOT is generally safe and well tolerated, and the incidence of
adverse events is reportedly quite low (3). We herein present a case
with rare complications during HBOT and discuss the appropriate
management of HBOT.
CASE PRESENTATION
A 31-year-old man without significant medical history was trans-
ported to the emergency department of a local hospital after being
rescued from a fire in his apartment. The patient sustained no ap-
parent burns on the body surface but had much soot in the nasal
cavity, and bronchoscopy revealed swelling of the larynx, with
serum carboxyhemoglobin level of 27.7%. The patient was diag-
nosed with inhalation injury and CO poisoning, and after endotra-
cheal intubation he was transferred to our emergency department
for the purpose of HBOT.
At our emergency department the patient was under sedation
with Richmond Agitation-Sedation Scale of -1, with serum carboxy-
hemoglobin level of 3.7%. Significant neurological deficit could not
be pointed out and no apparent seizures were seen. On the day of
admission, the first HBOT session was carried out using Kawasaki
KHO-302A (multiplace chamber), under the condition of 2.8 at-
mosphere absolute (ATA) for 90 minutes without any medical
equipment like monitor or syringe pumps, which ended unevent-
fully (Figure 1).
On day 2, before the second HBOT session, the patient was al-
most alert with a Glasgow Coma Scale score of E4VTM6 and with
stable respiratory status (Figure 2a). Laboratory exams and arte-
rial blood gas analysis before the second session showed serum
creatinine kinase level of 149 IU/L, serum carboxyhemoglobin
level of 1.7%, partial pressure of oxygen level in arterial blood of
614.9 mmHg, and partial pressure of carbon dioxide level in arterial
blood of 41.9 mmHg, respectively. Seventy minutes into the proce-
dure under the condition of constant pressure of 2.8 ATA, the pa-
tient suddenly experienced a generalized tonic-clonic seizure.
During the seizure the patient’s radial artery was bilaterally well
palpable. The accompanying doctor administered 30 mg of intrave-
nous propofol to stop the convulsion and decided to terminate the
HBOT session. During decompression, the patient developed
frothy secretions through the endotracheal tube. After the second
HBOT session, PaO2/FiO2 ratio of 68.1 in arterial blood gas indi-
cated impaired oxygenation. Elevated serum creatinine kinase
level of 671 IU/L and a serum lactate level of 64 mg/dL were both
compatible with the occurrence of generalized seizures. Neither a
serum creatine kinase-muscle/brain(CK-MB) nor cardiac enzyme
levels were elevated. Chest X-ray revealed bilateral pulmonary
edema (Figure 2b) and echocardiography showed normal cardiac
function, indicating that the pulmonary edema resulted from
HBOT, not from direct cardiovascular events ; thus, the patient
was placed on mechanical ventilation in the intensive care unit
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(ICU). Head computed tomography (CT) scan showed no abnor-
malities that could explain the convulsion (Figure 3). We decided
not to perform any more HBOT sessions. Subsequently, seizures
did not recur, and respiratory status improved without no signifi-
cant signs of infection or allergy in a couple of days under con-
servative therapy (Figure 2c). The patient was discharged from
the ICU on day 6 without any delayed neurological sequelae associ-
ated with CO poisoning afterwards.
DISCUSSION
We experienced a case of simultaneous convulsive seizure and
pulmonary edema during HBOT. Pulmonary edema and convul-
sion during HBO rarely occur as separate events (4, 5), and their
simultaneous occurrence has not been reported. The present case
has two clinically significant implications.
First, an emergent HBOT should be performed in a multiplace
chamber (6, 7). Well known major complications of HBOT include
barotrauma and oxygen toxicity (3), however, the exact mecha-
nism underlying complication during HBOT is not fully estab-
lished. The convulsive seizure in the present case is considered to be
attributable to oxygen toxicity to the central nervous system be-
cause convulsion did not occur before the initiation of HBOT and
recur after the cessation of HBOT, and there was no other apparent
reason for the convulsion on the head CT image or physical ex-
amination. Although the direct action of CO poisoning could in-
duce seizure, CO toxicity was not considered to the cause of the
seizure in the present case since a serum carboxyhemoglobin level
had been within normal range from the admission to our hospital
and the patient did not present either any neurological deficit
throughout the entire period or delayed neurological sequelae
associated with CO poisoning afterwards. The etiology of pulmo-
nary edema in the present case remains unclear but could possibly
result from HBOT, because the echocardiogram and electrocar-
diogram both yielded normal findings, and no other apparent rea-
sons for the pulmonary edema such as infection, allergic reaction
were detected. The other possible cause is neurogenic pulmonary
edema secondary to the seizure because neurogenic pulmonary
edema can occur following generalized seizure (8). In addition to
adverse side effects and complications directly associated with
HBOT, various unexpected events could occur because those who
require emergent HBOT are generally critically ill. Moreover, be-
cause an emergent HBOT is recommended within 24 hours after
the exposure to CO poisoning (2), in many cases HBOT is initiated
before completely grasping the patients’ medical background.
Therefore, HBOT for acute indications should be performed not in a
monoplace chamber, but in a multiplace chamber, where a well -
trained physician can accompany the patient to immediately detect
subtle changes in their condition.
Second, medical equipment inside the hyperbaric chamber would
lead to the safe and efficient management of patients undergoing
HBOT. Although those who require emergent HBOT are criti-
cally ill and require monitoring or mechanical support, almost all
medical devices are not permitted to be used under hyperbaric
conditions due to safety concerns in Japan (7). Our facility, Kyoto
University Hospital, equipped with a multiplace hyperbaric cham-
ber for HBOT and receives referrals from many other hospitals in
the Kansai area, does not have such medical equipment suitable for
use under hyperbaric conditions. In contrast, medical equipment
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Figure 2
a) Chest X-ray showed no abnormality just before HBOT on the second day after admission.
b) Chest X-ray showed bilateral pulmonary edema without cardiomegaly just after termination of the second HBOT session.
c) Chest X-ray showed improvement of the pulmonary edema 1 day after the second HBOT session.
Figure 1
The treatment protocol of hyperbaric oxygen therapy for this case of CO
poisoning -a total of 90 minutes procedure ; 2.8 ATA for 60 minutes and 15
minutes each for compression and decompression.
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certified by manufacturers are widely used in European countries
(9). Risk factors for seizures associated with HBOT include hyper-
capnia (4). In the present case we were forced to supervise the
patient without any medical equipment like monitoring devices or
syringe pumps. Mechanical monitoring of respiratory rate or cap-
nometer would have prevented the occurrence of seizure in this
case. Thus, sufficient medical equipment could be beneficial for the
safe and efficient management of patients.
In Japan, many emergent HBOT sessions are forced to be per-
formed in monoplace hyperbaric chambers because of a lack of
multiplace hyperbaric chambers. We hereby propose placement of
regional HBO centers, where a multiplace hyperbaric chamber, as
well as medical equipment suitable for use under hyperbaric condi-
tions are accessible from each region.
CONCLUSION
we present a rare case of simultaneous convulsive seizure and
pulmonary edema during HBOT. Through this case, two signifi-
cant clinical suggestions were obtained. First, HBOT for acute
indications should be performed in multiplace chambers, so that
accompanying physicians can treat the various expected and unex-
pected adverse events should they occur. Second, medical equip-
ment like monitoring devices or syringe pumps available under
hyperbaric conditions should be introduced in Japan. As CO poi-
soning is one of the leading causes of poison-associated deaths,
prompt improvement in the Japanese HBOT environment is re-
quired.
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Figure 3
Head computed tomography scan revealed no abnormalities just after
termination of the second HBOT session.
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